Search

Your search keyword '"Kurgansky N"' showing total 11 results

Search Constraints

Start Over You searched for: Author "Kurgansky N" Remove constraint Author: "Kurgansky N"
11 results on '"Kurgansky N"'

Search Results

1. PROSPECTIVE REAL WORLD EVIDENCE: USE OF BRENTUXIMAB VEDOTIN AS CONSOLIDATION THERAPY AFTER AUTOLOGOUS TRANSPLANT IN HODGKIN LYMPHOMA. AN INTERIM ANALYSIS, ON BEHALF OF GATLA

2. P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA

3. P1081: PET-ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG TERM FOLLOW UP OF THE GATLA LH-05 TRIAL

4. PET‐ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG TERM FOLLOW UP OF THE GATLA LH‐05 TRIAL

5. SAFETY AND EFFICACY ANALYSIS OF ELDERLY PATIENTS TREATED WITHIN THE GATLA HL-05 CLINICAL TRIAL: PET ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA

6. Intra-twenty-four-hours rhythm in correlates of psychological state

7. Creation of adaptive intelligence tests with a proven test material

8. Nebylitsynfs principles and assessment of psychological states (to the 80 anniversary of V.D. Nebylitsyn birth date)

9. Approaches to psychometrics of sychological states

10. Benefits of BV-AVD (Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) versus ABVD (doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine) in patients with advanced-stage Hodgkin's lymphoma: an analysis of the ECHELON 1 trial by the GATLA group using the Delphi Method.

11. PET-adapted therapy after three cycles of ABVD for all stages of Hodgkin lymphoma: results of the GATLA LH-05 trial.

Catalog

Books, media, physical & digital resources